TrialJAMA neurology2018
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
Joseph Jankovic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
174 papers cite itlatest 60 shown
this paperpooled ittrialcites it